As of 2026-03-29, 广药集团（白云山）'s data on the DeepSeek platform in the 制药企业 category shows: The overall mention rate is 0.00%, below the industry average by 10.4 percentage points, with significant room for improvement. The first mention rate is only 0.00%, it is recommended to enhance first-position exposure in AI model responses. Negative mention rate (0.00%) has exceeded positive (0.00%), it is recommended to immediately initiate reputation repair. Among 6 competitors in the same category, 广药集团（白云山）'s overall mention rate surpasses 0 brands. AIGeo recommends combining the above data to formulate targeted brand monitoring strategies to further enhance brand visibility and reputation in the AI search ecosystem.
广药集团（白云山）'s Mention Rate is 0.00%, lower than 0.6% of competitors
广药集团（白云山）'s First Mention is 0.00%, lower than 0.9% of competitors
广药集团（白云山）'s Preferred Rate is 0.00%, lower than 100.0% of competitors
广药集团（白云山）'s Positive Rate is 0.00%, lower than 8.9% of competitors
广药集团（白云山）'s Negative Rate is 0.00%, higher than 96.3% of competitors
| Competitor | Mention Rate | First Mention | Preferred Rate | Positive Rate | Negative Rate | Actions |
|---|---|---|---|---|---|---|
| 礼礼来 | 63.27% | 32.65% | 50% | 59.18% | 4.08% | View Details |
| 诺诺和诺德 | 59.18% | 6.12% | 0% | 42.86% | 20.41% | View Details |
| 罗罗氏 | 53.06% | 8.16% | 21.43% | 46.94% | 8.16% | View Details |
| 强强生 | 32.65% | 10.2% | 0% | 26.53% | 10.2% | View Details |
| 辉辉瑞 | 32.65% | 0% | 0% | 24.49% | 16.33% | View Details |
| 诺诺华 | 28.57% | 2.04% | 7.14% | 24.49% | 4.08% | View Details |
| 广广药集团（白云山） (Current Brand) | 0% | 0% | 0% | 0% | 0% | View Details |
